InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (5 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Soni Manmeet Singh, Chief Financial Officer. Director active across 2 companies, notably Reata Pharmaceuticals INC. Aggregated, 15 reports have been logged. Split: 2 buys · 5 sells. Total volume traded: €7.1m. Activity tracked since 31 December 2021. The latest transaction was filed on 21 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Soni Manmeet Singh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
53,361 shares@ US$18.7413.2% of flowCommon StockSEC:0001569769-25-000002:0
44,052 shares@ US$22.7016.1% of flowCommon StockSEC:0001599298-24-000136:0
2,976,190 shares@ US$1.6883.9% of flowCommon StockSEC:0001569769-23-000007:0
Canonical exit: 11 Jan 2024 (T+90)
62,621 sharesClass A common stockSEC:0000899243-23-019540:0
1,755 shares@ US$168.41359.8% of flowClass A common stockSEC:0001209191-23-046306:0
75,000 sharesClass A common stockSEC:0001209191-23-044009:0
6,000 shares0Class A common stockSEC:0001209191-23-041931:0
4,711 shares@ US$99.617315.8% of flowClass A common stockSEC:0001209191-23-037043:0
12,440 shares@ US$84.320134.9% of flowClass A common stockSEC:0001209191-23-030223:0
50,000 shares0Class A common stockSEC:0001209191-23-028269:0
622 shares@ US$84.6951.8% of flowClass A common stockSEC:0001209191-23-017235:0
3,587 shares@ US$87.9710.8% of flowClass A common stockSEC:0001209191-23-016339:0
23,513 shares0Class A common stockSEC:0001209191-23-001143:0
50,000 shares0Class A common stockSEC:0001209191-22-001633:0
16,000 shares@ US$26.222815.5% of flowClass A common stockSEC:0001209191-22-000391:0
Canonical exit: 31 Mar 2022 (T+90)
15 of 15 declarations
About Soni Manmeet Singh
Soni Manmeet Singh is Chief Operating Officer and Chief Financial Officer, with 15 filings in total. Across the 15 sampled filings, purchases amount to EUR 5115775 and sales to EUR 2019458, with filings spanning from 2022-01-04 to 2025-10-23. The filings concern Reata Pharmaceuticals INC and Summit Therapeutics Inc., and the modal transaction nature is Attribution.
